Breaking News
October 19, 2018 - URMC researchers discover new approach to deliver therapeutics to the brain
October 19, 2018 - Middlemen suppliers can increase drug prices and hospital bills, say Johns Hopkins researchers
October 19, 2018 - $11 million NIH grant for Clemson University helps launch new center for musculoskeletal research
October 19, 2018 - A new approach identified to control Zika virus, dengue fever
October 19, 2018 - Head Blows Without Concussion May Not Damage Brain, Study Claims
October 19, 2018 - US opioid use not declined, despite focus on abuse and awareness of risk
October 19, 2018 - Next-generation RNA sequencing technology sheds new light on human mitochondrial diseases
October 19, 2018 - UT Southwestern biochemist receives 2019 Breakthrough Prize in Life Sciences for innate immunity discovery
October 19, 2018 - The immune system also plays a key role in day-to-day function of healthy organs
October 19, 2018 - New tool may reveal how the brain structure impacts brain activity, human behavior
October 19, 2018 - Trump Administration announces ‘Winning on Reducing Food Waste’ initiative
October 19, 2018 - For-profit nursing home residents more likely to experience health issues caused by substandard care
October 19, 2018 - Incidence of stroke has risen steadily among marijuana users, show studies
October 19, 2018 - Conceptual framework proposed to examine role of exercise in multiple sclerosis
October 19, 2018 - Near infrared spectroscopy technique for accurate evaluation of chondral injuries
October 19, 2018 - Scientists receive $5.1 million grant to develop stem cell-based therapy for blinding retinal conditions
October 19, 2018 - Shorter physician encounters associated with antibiotic prescribing
October 19, 2018 - In the Spotlight: Enjoying research and exploring opportunities
October 19, 2018 - Physical activity lowers cardiovascular mortality risk in frail older adults
October 19, 2018 - New imaging tool helps visualize how sound-induced vibrations travel through the ear
October 19, 2018 - Key insights into the application, production of bioactive materials
October 19, 2018 - New urea sorbent could speed up the development of wearable artificial kidney
October 19, 2018 - Intensive care patients’ muscles less able to use fats for energy
October 19, 2018 - FDA Advisory Committee Recommends Approval of Dsuvia for the Treatment of Moderate-to-Severe Acute Pain
October 19, 2018 - 48,XXXY syndrome – Genetics Home Reference
October 19, 2018 - Physical exercise improves the elimination of toxic proteins from muscles
October 19, 2018 - How a new system improved wait times for Stanford kidney transplant patients
October 19, 2018 - Nutrition has bigger positive impact on bone mass and strength than exercise
October 19, 2018 - Study finds lack of progress in media representation of nurses over last 20 years
October 19, 2018 - Many people have trouble understanding differences between OCD and OCPD
October 19, 2018 - New family planning app found to be as effective as modern methods
October 19, 2018 - Gastric Banding, Metformin Similar for Improving Glycemia
October 19, 2018 - Physiologist publishes findings on the role of the protein titin in muscle contraction
October 19, 2018 - What digital health companies need to do to succeed
October 19, 2018 - N. Carolina Sees Alarming Spike in Heart Infections Among Opioid Users
October 19, 2018 - Video monitoring of TB therapy works well in urban and rural areas
October 19, 2018 - Determining acid-neutralizing capacity for OTC antacids
October 19, 2018 - Males who spend more time taking care of kids have greater reproductive success
October 18, 2018 - Study to explore bioethics of brain organoids
October 18, 2018 - Environmental conditions may drive development of multiple sclerosis
October 18, 2018 - Genetically modifying zebrafish provides more accurate disease models
October 18, 2018 - Purdue Pharma, Eisai announce positive topline results from Phase 3 study of lemborexant
October 18, 2018 - 5 Strength-Training Mistakes to Avoid
October 18, 2018 - Immune system’s balancing act keeps bowel disease in check
October 18, 2018 - Anti-inflammatory drug effective for treating lymphedema symptoms | News Center
October 18, 2018 - Keeping Your Voice Young
October 18, 2018 - One-time universal screening recommended to tackle increase in hepatitis C
October 18, 2018 - Researchers to develop new stem cell-based strategies for treating vision disorders
October 18, 2018 - Detecting epigenetic signature may help people stay ahead of inflammatory bowel disease
October 18, 2018 - Understanding AFib: Slowing down the dancing heart
October 18, 2018 - Using NMR to Reduce Fraud
October 18, 2018 - New automated model identifies dense breast tissue in mammograms
October 18, 2018 - Mysterious polio-like illness baffles medical experts while frightening parents
October 18, 2018 - Cases of Acute Flaccid Myelitis on the rise across U.S.
October 18, 2018 - Dietary fiber reduces brain inflammation during aging
October 18, 2018 - New tool could help prioritize recovery efforts for the poorest hit by natural disasters
October 18, 2018 - Hundreds of dietary supplements shown to contain unapproved drugs
October 18, 2018 - Active Pharmaceuticals ID’d in >700 Dietary Supplements
October 18, 2018 - Cell death protein also damps inflammation
October 18, 2018 - AI pathology diagnostic tool developed using deep learning technology from Olympus
October 18, 2018 - Health Highlights: Oct. 15, 2018
October 18, 2018 - Largest study of ‘post-treatment controllers’ reveals clues about HIV remission
October 18, 2018 - Bad Blood in Silicon Valley: A conversation with John Carreyrou
October 18, 2018 - ANTRUK’s Annual Lecture sends out message on shortage of funds for antibiotic research
October 18, 2018 - NAM special publication outlines steps to ensure interoperability of health care systems
October 18, 2018 - Novel method uses just a drop of blood to monitor effect of lung cancer therapy
October 18, 2018 - New blood test could spare cancer patients from unnecessary chemotherapy
October 18, 2018 - Training young researchers to work with data volumes arising in the health sector
October 18, 2018 - New Metrohm IC method is reliable and convenient to use for zinc oxide assay
October 18, 2018 - Global AIDS, TB fight needs more money: health fund
October 18, 2018 - Understanding the forces that cause sports concussions
October 18, 2018 - Research points to new target for treating periodontitis
October 18, 2018 - New tool improves assessment of postpartum depression symptoms
October 18, 2018 - From Biopsy to Diagnosis
October 18, 2018 - Sexual harassment and assault linked to worse physical/mental health among midlife women
October 18, 2018 - Stumped by medical school? A Q&A with a learning specialist
October 18, 2018 - Report predicts life expectancy in 2040, Spain comes out on top
October 18, 2018 - Self-lubricating condoms may help raise condom usage
October 18, 2018 - Targeting immune checkpoints in microglia could reduce out-of-control neuroinflammation
October 18, 2018 - Study finds changes in antiepileptic drug metabolism during different trimesters of pregnancy
Seeing prostate cancer in a new light

Seeing prostate cancer in a new light

image_pdfDownload PDFimage_print
Credit: University of Dundee

A new method offering more successful diagnosis and management of prostate cancer has been identified by researchers at the University of Dundee.

They say an ultrasound process called shear wave elastography (SWE) has been shown to offer much greater accuracy and reliability in diagnosis of prostate cancer, while being a non-invasive and cheaper method than those currently used.

Prostate cancer is the most common cancer in men in the UK, with over 47,000 new cases diagnosed every year. Recent high-profile cases include the University’s former Rector Stephen Fry.

In the UK, 1 in 8 men will get prostate cancer at some point in their lives. Men aged 50 or over, men with a family history of prostate cancer and black men are more at risk of getting prostate cancer.

Yet current methods of diagnosis and treatment are significantly flawed. The most commonly used tests for prostate cancer include the PSA blood test, a physical examination of the prostate (known as a digital rectal examination or DRE), MRI scans, and a biopsy.

Each carries significant problems. The PSA test are not offered as standard treatment and the results can be unreliable. The DRE is not good at identifying which cancers are benign and which need treatment. MRI scans are not available across the country and cannot always give a definitive answer. The biopsy is invasive, carries risk of infection and is expensive.

Ghulam Nabi, Professor of Surgical Uro-oncology at the University of Dundee and Lead for Prostate Cancer Surgery with NHS Tayside, said, “Prostate cancer is one of the most difficult to pinpoint. We are still in a position where our diagnosis of prostate cancer is extremely inefficient, leading to unnecessary treatments for many patients.

“The new method we have developed shows we can achieve much greater levels of diagnosis, including identifying the difference between cancerous and benign tissue without the need for invasive surgery.”

The results of the Dundee research are published in the Journal of Urology. The project was funded by Prostate Cancer UK with support from the Movember Foundation.

News of the research has been welcomed by Stephen Fry, a former Rector of the University who recently revealed he had undergone surgery for prostate cancer.

Stephen said, “As a proud honorary doctor and one time Rector of Dundee University as well as a recent survivor of prostate cancer, it is doubly, triply exciting to hear of the new techniques in diagnostic imaging that have been going on at the famed University of Dundee Medical School.

“Anyone who has been in my position will know that when it comes to this pernicious disease early screening and diagnosis is the absolute key to a successful outcome. The news of this breakthrough comes at a time when prostate cancer is being pushed to the forefront of our consciousness in the UK, not least because of the disturbing upward trend in its prevalence. So hurrah for Dundee University and Medical School and a huge thank you to Professor Nabi and his team for their work in developing this new weapon in the war against a deadly killer.”

The method developed by Professor Nabi and colleagues involves targeting the prostate with ultrasound. Cancerous tissue is stiffer than normal tissue, so when the shear waves are slowed as they pass through it. This effect can be measured and used to develop images of the cancerous area, with a definition and accuracy that outstrips other scanning methods such as MRI.

The technology was able to detect 89 per cent of prostate cancers and could identify more aggressive cancers and those beginning to spread outside the prostate.

“We have been able to show a stark difference in results between existing techniques such as MRI and SWE,” said Professor Nabi. “We have had cases where the SWE technique has picked up cancers which MRI did not reveal.

“It is like someone has turned the lights on in a darkened room. We can now see with much greater accuracy what tissue is cancerous, where it is and what level of treatment it needs.

“This is a significant step forward in detection and management of prostate cancer. Our study was localised here in Dundee and involved around 200 patients. We really need to see this looked at on a wider scale to build more data but there is clearly the potential to really change the way we manage prostate cancer.”

SWE technology is already used in breast cancer and liver diseases. To make it applicable to prostate cancer a special probe had to be developed.

Cheng Wei, a postdoctoral researcher who worked on the project with Professor Nabi and colleagues, said, “The technology is now available which allows us to apply SWE imaging to prostate cancer, with very impressive results.”

Simon Grieveson, Head of Research Funding at Prostate Cancer UK, said, “With one man dying every 45 minutes from prostate cancer in the UK, the need for a more reliable test which can identify dangerous forms of the disease earlier is greater than ever.

“This research has shown the potential of a novel form of ultrasound called shear wave elastography in detecting clinically significant prostate cancer. If proven to be effective, this could lead to a more accurate and cost effective option than current diagnostic tests. This promising new technique now needs to be tested in a much larger number of men to confirm just how well it can detect the aggressive cancers, whilst also ruling out those who do not have prostate cancer. We look forward to further results in this area.”

Paul Villanti, Executive Director, Programs at the Movember Foundation said, “This is a promising development that addresses the limitations of current prostate cancer diagnosis tests, to provide the best possible outcomes for men. It’s all thanks to the amazing support of our Mo Bros & Mo Sistas over the years who have made these breakthroughs happen through their fundraising efforts.”


Explore further:
PSMA PET/CT clearly differentiates prostate cancer from benign tissue

Journal reference:
Journal of Urology

Provided by:
University of Dundee

Tagged with:

About author

Related Articles